Ignite Creation Date:
2024-05-05 @ 7:06 PM
Last Modification Date:
2024-10-26 @ 9:44 AM
Study NCT ID:
NCT00607581
Status:
COMPLETED
Last Update Posted:
2012-02-10
First Post:
2008-01-22
Brief Title:
Cyclophosphamide Lenalidomide and Dexamethasone CLD for Previously Treated Patients With AL Amyloidosis
Sponsor:
Fondazione IRCCS Policlinico San Matteo di Pavia
Organization:
Fondazione IRCCS Policlinico San Matteo di Pavia
Organization Data
Organization:
Fondazione IRCCS Policlinico San Matteo di Pavia
Class:
OTHER
Study ID:
AC-003-IT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fondazione IRCCS Policlinico San Matteo di Pavia
Lead Sponsor Class:
OTHER
Responsible Party:
Giampaolo Merlini
Responsible Party Title:
Director Amyloidosis Treatment and Research Center
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Fondazione IRCCS Policlinico San Matteo di Pavia
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene Corporation | INDUSTRY |